FINGOLIMOD BGR 0,5 mg, gélule — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930212226
  • CIP7 3021222
  • CIS 67410227

What the source publishes

Holder
BIOGARAN
Active ingredients
FINGOLIMOD, CHLORHYDRATE DE FINGOLIMOD
Form
gélule
Package
plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE
Marketing status
Déclaration de commercialisation
Authorised on
2020-07-23
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930212226
{
  "cis": "67410227",
  "cip7": "3021222",
  "form": "gélule",
  "name": "FINGOLIMOD BGR 0,5 mg, gélule — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 gélule(s)",
  "cip13": "3400930212226",
  "holder": "BIOGARAN",
  "routes": [
    "orale"
  ],
  "holders": [
    "BIOGARAN"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "580.30",
  "authorisedOn": "2020-07-23",
  "compositions": [
    {
      "name": "FINGOLIMOD",
      "nature": "FT",
      "strength": "0,5 mg",
      "linkageNumber": "1",
      "substanceCode": "85211",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "CHLORHYDRATE DE FINGOLIMOD",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "97368",
      "dosageReference": null,
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE",
  "dispensingFee": "1.02",
  "medicinePrice": "579.28",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "FINGOLIMOD BGR 0,5 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2025-10-15",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "FINGOLIMOD",
    "CHLORHYDRATE DE FINGOLIMOD"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services NEUROLOGIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription initiale hospitalière annuelle",
    "liste I",
    "la première administration doit être effectuée en milieu hospitalier",
    "prescription réservée aux spécialistes et services NEUROPEDIATRIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930212226"